Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

This study is currently recruiting participants.

Study NCT00107289 Information provided by National Cancer Institute (NCI)

First Received: April 5, 2005 Last Updated: November 27, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)